Denmark's Novo Nordisk has received FTC approval to acquire three Catalent plants for $11.7 billion
AK&M 16 December 2024 14:20 The Danish investment company Novo Nordisk A/S has received approval from the US Federal Trade Commission (FTC) to acquire the production assets of Catalent Inc., one of the world's largest pharmaceutical companies. …